Diagnosis and management of amebiasis

Clinical Infectious Diseases

Volumn 29, Issue 5, 1999, Pages 1117-1125

  Petri Jr , William A ^a,c   Singh, Upinder ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIAMEBIC AGENT; CHLOROQUINE; DIIODOHYDROXYQUIN; DILOXANIDE FUROATE; METRONIDAZOLE; PAROMOMYCIN;

AMEBIASIS; CLINICAL EXAMINATION; HISTOPATHOLOGY; HUMAN; LABORATORY DIAGNOSIS; NOTE; PATHOGENESIS; PRIORITY JOURNAL;

AMEBIASIS; HUMANS;

EID: 0033510451     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313493     Document Type: Note

References (69)

1. 1. WHO/PAHO/UNESCO report of a consultation of experts on amoebiasis. Weekly Epidemiological Report of the World Health Organization 1997;72:97-9.
2. 2. Sargeaunt PG, Williams JE, Grene JD. The differentiation of invasive and non-invasive Entamoeba histolytica by isoenzyme electrophoresis. Trans R Soc Trop Med Hyg 1978;72:519-21.
3. 3. Tannich H, Horstmann RD, Knobloch J, Arnold HH. Genomic DNA differences between pathogenic and nonpathogenic Entamoeba histolytica. Proc Natl Acad Sci USA 1989;86:5118-22.
4. 4. Haque R, Ali IKM, Akther S, Petri WA Jr. Comparison of PCR, isoenzyme analysis, and antigen detection for diagnosis of Entamoeba histolytica infection. J Clin Microbiol 1998;36:449-52.
5. 5. Mirelman D, Bracha R, Wexler A, Chayen A. Changes in isozyme patterns of a cloned culture of nonpathogenic Entamoeba histolytica during axenizalion. Infect Immun 1986;54:827-32.
6. 6. Clark CG, Diamond LS. Entamoeba histolytica - an explanation for the reported conversion of nonpathogenic amebae to the pathogenic form. Exp Parasitol 1993;77:456-60.
7. 7. Lucht E, Evengard B, Skott J, Pehrson P, Nord CE. Entamoeba gingivalis in human immunodeficiency virus type 1 infected patients with periodontal disease. Clin Infect Dis 1998;27:471-3.
8. 8. Bruchhaus I, Jacobs T, Denart M, Tannich E. Pyrophosphate-dependent phosphofructokinase of Entamoeba histolytica molecular cloning, recombinant expression, and inhibition by pyrophosphate analogues. Biochem J 1996;316:57-63.
9. 9. Flores BM, Stanley SL, Yong TS, et al. Surface localization, regulation, and biologic properties of the 96-kDa alcohol aldehyde dehydrogenase (EhADH2) of pathogenic Entamoeba histolytica. J Infect Dis 1996;173: 226-31.
10. 10. Mai Z, Ghosh S, Frisardi M, Rosenthal B, Rogers R, Samuelson J. Msp60 is targeted to a cryptic mitochondrion-derived organelle ("Crypton") in the microaerophilic protozoan parasite Entamoeba histolytica. Mol Cell Biol 1999;19:2198-205.
11. 11. Tovar J, Fischer A, Clark CG. The mitosome, a novel organelle related to mitochondria in the amitochondriate parasite Entamoeba histolytica. Mol Microbiol 1999;32:1013-21.
12. 12. Singh U, Rogers JB, Mann BJ, Petri WA Jr. Transcription initiation is controlled by three core promoter elements in the hg15 gene of the protozoan parasite Entamoeba histolytica. Proc Natl Acad Sci USA 1997;94:8812-7.
13. 13. Willhoeft U, Tannich E. The electrophoretic karyotype of Entamoeba histolytica. Mol Biochem Parasitol 1999;99:41-53.
14. 14. Cho J, Eichinger D. Crithidia fasciculata induces encystation of Entamoeba invadens in a galactose-dependent manner. J Parasitol 1998;84:705-10.
15. 15. Göttke MU, Keller K, Belley A, et al. Functional heterogeneity of colonic adenocarcinoma mueins for inhibition of Entamoeba histolytica adherence to target cells. J Eukaryot Microbiol 1998;45:17S-23S.
16. 16. Ravdin JI, Guerrant RL. Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes. J Clin Invest 1981;68:1305-13.
17. 17. Li E, Becker A, Stanley SL. Use of Chinese hamster ovary cells with altered glycosylation patterns to define the carbohydrate specificity of Entamoeba histolytica adhesions. J Exp Med 1988;167:1725-30.
18. 18. Petri WA Jr, Chapman MD, Snodgrass T, Mann BJ, Broman J, Ravdin JI. Subunit structure of the galactose and N-acetyl-D-galactosamine inhibitable adherence lectin of Entamoeba histolytica. J Biol Chem 1989;264:3007-12.
19. 19. Dodson JM, Lenkowski PW Jr, Eubanks AC, et al. Infection and immunity mediated by the carbohydrate recognition domain of the Entamoeba histolytica Gal/GalNAc lectin. J Infect Dis 1999;179:460-6.
20. 20. Vines RR, Ramakrishnan G, Rogers JB, Lockhart LA, Mann BJ, Petri WA Jr. Regulation of adherence and virulence by the Entamoeba histolytica lectin cytoplasmic domain, which contains a β2 integrin motif. Mol Biol Cell 1998;9:2069-79.
21. 21. Ragland BD, Ashley LS, Vaux DL, Petri WA Jr. Entamoeba hislolytica: target cells killed by trophozoites undergo apoptosis which is not blocked by bcl-2. Exp Parasitol 1994;79:460-7.
22. 22. Seydel KB, Stanley SL Jr. Entamoeba histolytica induces host cell death in amebic liver abscess by a non-Fas-dependent, non-tumor necrosis factor alpha-dependent pathway of apoptosis. Infect Immun 1998;66:2980-3.
23. 23. Huston CD, Hahn CS, Petri WA Jr. Role of host cell caspase 3 in apoptotic killing by Entamoeba histolytica. In: Program and abstracts of the annual meeting of the American Society of Tropical Medicine and Hygiene, Washington, DC, 29 November-2 December, 1999. Northbrook, IL: 1999.
24. 24. Berninghausen O, Leippe M. Necrosis versus apoptosis as the mechanism of target cell death induced by Entamoeba histolytica. Infect Immun 1997; 65:3615-21.
25. 25. Braga LL, Ninomiya H, McCoy JJ, et al. Inhibition of the complement membrane attack complex by the galactose-specific adhesin of Entamoeba histolytica. J Clin Invest 1992;90:1131-7.
26. 26. Jacobs T, Bruchhaus I, Dandekar T, Tannich E, Leippe M. Isolation and molecular characterization of a surface-bound proteinase of Entamoeba histolytica. Mol Microbiol 1998;27:269-76.
27. 27. Ankri S, Stolarsky T, Mirelman D. Antisense inhibition of expression of cysteine proteinases does not affect Entamoeba histolytica cytopathic or haemolytic activity but inhibits phagocytosis. Mol Microbiol 1998;28: 777-85.
28. 28. Tran VQ, Herdman DS, Torian BE, Reed SL. The neutral cysteinc proteinase of Entamoeba histolytica degrades IgG and prevents its binding. J Infect Dis 1998;177:508-11.
29. 29. Arhets P, Olivo JC, Gounon P, Sansonetti P, Guillen N. Virulence and functions of myosin II are inhibited by overexpression of light meromyosin in Entamoeba histolytica. Mol Biol Cell 1998;9:1537-47.
30. 30. Caballero-Salcedo A, Viveros-Rogel M, Salvatierra B, et al. Scroepidemiology of amebiasis in Mexico. Am J Trop Med Hyg 1994;50:412-9.
31. 31. Barwick RS, Uzicanin A, Lareau S, et al. Outbreak of amebiasis in Tbilisi, Republic of Georgia, 1998. In: Program and abstracts of the annual meeting of the American Society of Tropical Medicine and Hygiene, Washington, DC, 29 November-2 December1999. Northbrook, IL: 1999.
32. 32. Summary of notifiable diseases, United States. MMWR Morb Mortal Wkly Rep 1994;42.
33. 33. Weinke T, Friedrich-Janicke B, Hopp P, Janitschke K. Prevalence and clinical importance of Entamoeba histolytica in two high-risk groups: travelers returning from the tropics and male homosexuals. J Infect Dis 1990;161: 1029-31.
34. 34. F, de Lalla, Rinaldi E, Santoro D, et al. Outbreak of Entamoeba histolytica and Giardia lamblia infections in travellers returning from the tropics. Infection 1992;20:78-82.
35. 35. Nagakura K, Tachibana H, Tanaka T, et al. An outbreak of amebiasis in an institution for the mentally retarded in Japan. Jpn J Med Sci Biol 1989;42: 63-76.
36. 36. Takeuchi T, Okuzawa F, Nozaki T, et al. High seropositivity of Japanese homosexual men for amebic infection [letter]. J Infect Dis 1989;159:808.
37. 37. Secto RK, Rockey DC. Amebic liver abscess: epidemiology, clinical features, and outcome. West J Med 1999;170:104-9.
38. 38. Adams EB, MacLeod IN. Invasive amebiasis. II. Amebic liver abscess and its complications. Medicine 1977;56:325-34.
39. 39. Katzenstein D, Rickerson V, Braude A. New concepts of amebic liver abscess derived from hepatic imaging, serodiagnosis, and hepatic enzymes in 67 consecutive cases in San Diego. Medicine 1982;61:237-41.
40. 40. Barnes PF, DeCock KM, Reynolds TN, Ralls PW. A comparison of amebic and pyogenic abscess of the liver. Medicine 1987;66:472-83.
41. 41. Chuah SK, Chang-Chien CS, Sheen IS, et al. The prognostic factors of severe amebic liver abscess: a retrospective study of 125 cases. Am J Trop Med Hyg 1992;46:398-402.
42. 42. Shandera WX, Bollam P, Hashmey RH, Athey PA, Greenberg SB, White AC Jr. Hepatic amebiasis among patients in a public teaching hospital. South Med J 1998;91:829-37.
43. 43. Haque R, Faruque ASG, Hahn P, Lyerly DM, Petri WA Jr. Entamoeba histolytica and Entamoeba dispar infection in children in Bangladesh. J Infect Dis 1997;175:734-6.
44. 44. Gathiram V, Jackson TFGH. Frequency distribution of Entamoeba histolytica zymodemes in a rural South African population. Lancet 1985;1: 719-21.
45. 45. Martinez MC, Munoz O, Garduno G, et al. Pathogenic and non-pathogenic zymodemes of Entamoeba histolytica in a rural area of Mexico: concordance with serology, Arch Invest Med 1990;21(Suppl 1):147-52.
46. 46. Haque R, Ali IKM, Petri WA Jr. Prevalence and immune response to Entamoeba histolytica in preschool children in an urban slum of Dhaka, Bangladesh. Am J Trop Med Hyg 1999;60:1031-4.
47. 47. Haque R, Ali IKM, Clark CG, Petri WA Jr. A case report of Entamoeba moshkovskii infection in a Bangladeshi child. Parasitology International 1998;47:201-2.
48. 48. Irusen EM, Jackson TFHG, Simjee AE. Asymptomatic intestinal colonisation by pathogenic Entamoeba histolytica - prevalence, response to therapy, and pathogenic potential. Clin Infect Dis 1992;14:889-93.
49. 49. Adams EB, MacLeod IN. Invasive amebiasis. I. Amebic dysentery and its complications. Medicine 1977;56:315-24.
50. 50. Speelman P, McGlaughlin R, Kabir I, et al. Differential clinical features and stool findings in shigellosis and amoebic dysentery. Trans R Soc Trop Med Hyg 1987;81:549-51.
51. 51. Ellyson JH, Bezmalinovic Z, Parks SN, et al. Necrotizing amebic colitis: a frequently fatal complication. Am J Surg 1986;152:21-6.
52. 52. Aristizabal H, Acevedo J, Botero M. Fulminant amebic colitis. World J Surg 1991;15:216-21.
53. 53. De Villiers JP, Durra G. Amoebic abscess of the brain. Clin Radiol 1998; 53:307-9.
54. 54. Mirelman D, Nuchamowitz Y, Stolarsky T. Comparison of use of enzymelinked immunosorbent assay based kits and PCR amplification of rRNA genes for simultaneous detection of Entamoeba histolytica and E. dispar. J Clin Microbiol 1997;35:2405-7.
55. 55. Eubanks AC, Lyerly DM, Haque R, Petri WA. Evaluation of a new second generation ELISA specific for Entamoeba histolytica. In: Program and abstracts of the annual meeting of the American Society of Tropical Medicine and Hygiene, San Juan, Puerto Rico, 18-22 October 1998. Northbrook, IL: 1998.
56. 56. Gilman R, Islam M, Paschi S, Goleburn J, Ahmad F. Comparison of conventional and immunofluorescent techniques for the detection of Entamoeba histolytica in rectal biopsies. Gastroenterology 1980;78:435-9.
57. 57. Ralls PW. Focal inflammatory disease of the liver. Radiol Clin North Am 1998;36:377-89.
58. 58. Kimura K, Stoopen M, Reeder MM, Moncada R, Amebiasis: modern diagnostic imaging with pathological and clinical correlation. Semin Roentgenol 1997;32:250-75.
59. 59. Huston CD, Petri WA Jr, Amebiasis. In: Rakel RE, ed. Conn's current therapy. New York: W.B. Saunders (in press).
60. 60. Rajak CL, Gupta S, Jain S, Chawla Y, Gulati M, Suri S. Percutaneous treatment of liver abscesses: needle aspiration versus catheter drainage. AJR Am J Roentgenol 1998;170:1035-9.
61. 61. Tandon A, Jain AK, Dixit VK, Agarwal AK, Gupta JP. Needle aspiration in large amoebic liver abscess. Trop Gastroenterol 1997;18:19-21.
62. 62. Petri WA Jr, Ravdin JI. Protection of gerbils from amebic liver abscess by immunization with the galactose-specific adherence lectin of Entamoeba histolytica. Infect Immun 1991;59:97-101.
63. 63. Zhang T, Stanley SL Jr. Protection of gerbils from amebic liver abscess by immunization with a recombinant protein derived from the 170-kiloddalton surface adhesin of Entamoeba histolytica. Infect Immun 1994;62:2605-8.
64. 64. Zhang T, Cieslak PR, Foster L, Kuntz-Jenkins C, Stanley SL Jr. Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amoebic liver abscess in severe combined immunodeficient (SCID) mice. Parasite Immunol 1994;16:225-30.
65. 65. Soong CJG, Kainn KC, Abd-Alla M, Jackson TFHG, Ravdin JT. A recombinant cysteine-rich section of the Entamoeba histolytica galactose inhibitable lectin is efficacious as a subunit vaccine in the Gerbil model of amebic liver abscess. J Infect Dis 1995;171:645-51.
66. 66. Mann BJ, Burkholder BV, Lockhart LA. Protection in a gerbil model of amebiasis by oral immunization with Salmonella expressing the galactose N-acetyl D-galactosamine inhibitable lectin of Entamoeba histolytica. Vaccine 1997;15:659-63.
67. 67. Huston CD, Petri WA Jr. The host-pathogen interaction in amebiasis: Is a vaccine feasible? Fur J Clin Microbiol Infect Dis 1998;17:601-14.
68. 68. Salata RA, Pearson RP, Murphy CF, Ravdin JI. Interaction of human leukocytes with Entamoeba histolytica: killing of virulent amebac by the activated macrophage. J Clin Invest 1985;76:491-9.
69. 69. Denis M, Chadce K. Human neutrophils activated by interferon-gamma and tumor necrosis factor alpha kill Entamoeba histolytica trophozoites in vitro. J Leukoc Biol 1989;46:270-4.